Partners Capital Investment Group, LLP I Mab Transaction History

Partners Capital Investment Group, LLP

  • $5.26 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$4.01 - $12.34 $887,517 - $2.73 Million
-221,326 Closed
0 $0
Q2 2022

Aug 15, 2022
BUY
$8.27 - $18.43 $206,559 - $460,326
24,977 Added 12.72%
221,326 $2.5 Million
Q1 2022

May 16, 2022
BUY
$12.54 - $46.93 $1.07 Million - $4.01 Million
85,380 Added 76.94%
196,349 $3.19 Million
Q4 2021

Feb 14, 2022
BUY
$45.28 - $74.5 $5.02 Million - $8.27 Million
110,969 New
110,969 $5.26 Million

Others Institutions Holding IMAB

# of Institutions
44
Shares Held
16.4M
Call Options Held
3K
Put Options Held
1.9K
View Full List

About I-Mab

IMAB Quotes by TradingView
  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $95.6M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Partners Capital Investment Group, LLP Portfolio

Follow Partners Capital Investment Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Partners Capital Investment Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email